These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38943076)

  • 1. An exploratory randomised trial investigating feasibility, potential impact and cost effectiveness of link workers for people living with multimorbidity attending general practices in deprived urban communities.
    Kiely B; Hobbins A; Boland F; Clyne B; Galvin E; Byers V; Loomba S; O'Donnell P; Connolly D; Shea EO'; Smith SM
    BMC Prim Care; 2024 Jun; 25(1):233. PubMed ID: 38943076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Link workers providing social prescribing and health and social care coordination for people with multimorbidity in socially deprived areas (the LinkMM trial): protocol for a pragmatic randomised controlled trial.
    Kiely B; Clyne B; Boland F; O'Donnell P; Connolly D; O'Shea E; Smith SM
    BMJ Open; 2021 Feb; 11(2):e041809. PubMed ID: 33526499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a social prescribing intervention in North East England on adults with type 2 diabetes: the SPRING_NE multimethod study.
    Moffatt S; Wildman J; Pollard TM; Gibson K; Wildman JM; O'Brien N; Griffith B; Morris SL; Moloney E; Jeffries J; Pearce M; Mohammed W
    Public Health Res (Southampt); 2023 Mar; 11(2):1-185. PubMed ID: 37254700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The CARE Plus study - a whole-system intervention to improve quality of life of primary care patients with multimorbidity in areas of high socioeconomic deprivation: exploratory cluster randomised controlled trial and cost-utility analysis.
    Mercer SW; Fitzpatrick B; Guthrie B; Fenwick E; Grieve E; Lawson K; Boyer N; McConnachie A; Lloyd SM; O'Brien R; Watt GC; Wyke S
    BMC Med; 2016 Jun; 14(1):88. PubMed ID: 27328975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary care-based link workers providing social prescribing to improve health and social care outcomes for people with multimorbidity in socially deprived areas (the LinkMM trial): Pilot study for a pragmatic randomised controlled trial.
    Kiely B; Connolly D; Clyne B; Boland F; O'Donnell P; Shea EO; Smith SM
    J Multimorb Comorb; 2021; 11():26335565211017781. PubMed ID: 34094992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of Community-Links Practitioners in Areas of High Socioeconomic Deprivation.
    Mercer SW; Fitzpatrick B; Grant L; Chng NR; McConnachie A; Bakhshi A; James-Rae G; O'Donnell CA; Wyke S
    Ann Fam Med; 2019 Nov; 17(6):518-525. PubMed ID: 31712290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
    Bosanquet K; Adamson J; Atherton K; Bailey D; Baxter C; Beresford-Dent J; Birtwistle J; Chew-Graham C; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hamilton J; Hargate R; Hewitt C; Holmes J; Keding A; Lewis H; McMillan D; Meer S; Mitchell N; Nutbrown S; Overend K; Parrott S; Pervin J; Richards DA; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Gilbody S
    Health Technol Assess; 2017 Nov; 21(67):1-252. PubMed ID: 29171379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Group cognitive-behavioural programme to reduce the impact of rheumatoid arthritis fatigue: the RAFT RCT with economic and qualitative evaluations.
    Hewlett S; Almeida C; Ambler N; Blair PS; Choy E; Dures E; Hammond A; Hollingworth W; Kadir B; Kirwan J; Plummer Z; Rooke C; Thorn J; Turner N; Pollock J
    Health Technol Assess; 2019 Oct; 23(57):1-130. PubMed ID: 31601357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protocol for a mixed methods process evaluation of the LinkMM randomised controlled trial "Use of link workers to provide social prescribing and health and social care coordination for people with complex multimorbidity in socially deprived areas".
    Kiely B; O'Donnell P; Byers V; Galvin E; Boland F; Smith SM; Connolly D; O'Shea E; Clyne B
    HRB Open Res; 2021; 4():38. PubMed ID: 37901156
    [No Abstract]   [Full Text] [Related]  

  • 12. Patient-reported outcome measures for monitoring primary care patients with depression: the PROMDEP cluster RCT and economic evaluation.
    Kendrick T; Dowrick C; Lewis G; Moore M; Leydon GM; Geraghty AW; Griffiths G; Zhu S; Yao GL; May C; Gabbay M; Dewar-Haggart R; Williams S; Bui L; Thompson N; Bridewell L; Trapasso E; Patel T; McCarthy M; Khan N; Page H; Corcoran E; Hahn JS; Bird M; Logan MX; Ching BCF; Tiwari R; Hunt A; Stuart B
    Health Technol Assess; 2024 Mar; 28(17):1-95. PubMed ID: 38551155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sexual health promotion in people with severe mental illness: the RESPECT feasibility RCT.
    Hughes E; Mitchell N; Gascoyne S; Moe-Byrne T; Edmondson A; Coleman E; Millett L; Ali S; Dare C; Hewitt C; Johnson S; Llewellyn C; Mercer C; Nolan F; Walker C; Watson J
    Health Technol Assess; 2019 Dec; 23(65):1-136. PubMed ID: 31854292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behavioural modification interventions for medically unexplained symptoms in primary care: systematic reviews and economic evaluation.
    Leaviss J; Davis S; Ren S; Hamilton J; Scope A; Booth A; Sutton A; Parry G; Buszewicz M; Moss-Morris R; White P
    Health Technol Assess; 2020 Sep; 24(46):1-490. PubMed ID: 32975190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trial to improve health and reduce substance use in established psychosis (IMPaCT): cost-effectiveness of integrated psychosocial health promotion.
    Heslin M; Patel A; Stahl D; Gardner-Sood P; Mushore M; Smith S; Greenwood K; Onagbesan O; O'Brien C; Fung C; Ohlsen R; Hopkins D; Lowe P; Arbuthnot M; Mutatsa S; Todd G; Kolliakou A; Lally J; Stubbs B; Ismail K; David A; Murray R; Atakan Z; Gaughran F
    BMC Psychiatry; 2017 Dec; 17(1):407. PubMed ID: 29273021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
    Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
    Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A general practice intervention for people at risk of poor health outcomes: the Flinders QUEST cluster randomised controlled trial and economic evaluation.
    Reed RL; Roeger L; Kwok YH; Kaambwa B; Allison S; Osborne RH
    Med J Aust; 2022 May; 216(9):469-475. PubMed ID: 35388512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CollAborative care and active surveillance for Screen-Positive EldeRs with subthreshold depression (CASPER): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness.
    Lewis H; Adamson J; Atherton K; Bailey D; Birtwistle J; Bosanquet K; Clare E; Delgadillo J; Ekers D; Foster D; Gabe R; Gascoyne S; Haley L; Hargate R; Hewitt C; Holmes J; Keding A; Lilley-Kelly A; Maya J; McMillan D; Meer S; Meredith J; Mitchell N; Nutbrown S; Overend K; Pasterfield M; Richards D; Spilsbury K; Torgerson D; Traviss-Turner G; Trépel D; Woodhouse R; Ziegler F; Gilbody S
    Health Technol Assess; 2017 Feb; 21(8):1-196. PubMed ID: 28248154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of multimorbidity using a patient-centred care model: a pragmatic cluster-randomised trial of the 3D approach.
    Salisbury C; Man MS; Bower P; Guthrie B; Chaplin K; Gaunt DM; Brookes S; Fitzpatrick B; Gardner C; Hollinghurst S; Lee V; McLeod J; Mann C; Moffat KR; Mercer SW
    Lancet; 2018 Jul; 392(10141):41-50. PubMed ID: 29961638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The multimorbidity collaborative medication review and decision making (MyComrade) study: a pilot cluster randomised trial in two healthcare systems.
    Kirwan C; Hynes L; Hart N; Mulligan S; Leathem C; McQuillan L; Maxwell M; Carr E; Roche K; Walkin S; McCarthy C; Bradley C; Byrne M; Smith SM; Hughes C; Corry M; Kearney PM; McCarthy G; Cupples M; Gillespie P; Hobbins A; Newell J; Glynn L; Roshan D; Sinnott C; Murphy AW
    Pilot Feasibility Stud; 2022 Oct; 8(1):225. PubMed ID: 36195963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.